1-3 of 3
Justin Skoble
Close
Sort by
Journal Articles

CLL-1-Targeted Allogeneic CAR-T Cells Exhibit High on-Target Specificity and Potent Cytotoxicity in Preclinical Models of Acute Myeloid Leukemia

Brian Francica, Elizabeth Garner, Sai Namburi, Cian Colgan, Tristan Fowler, Devin Mutha, Art Aviles, Morena Stanaway, Raymond Guo, Zili An, Erin Kelly, Emilie Degagne, George Kwong, Leslie Edwards, Emma Jakes, McKay Shaw, Benjamin Schilling, Jeremy Huynh, Ricky Luu, Max Sidorov, Rhonda Mousali, Mikk Otsmaa, Peter Lauer, Justin Skoble, Steven Kanner
Journal: Blood
Blood (2023) 142 (Supplement 1): 6838.
https://doi.org/10.1182/blood-2023-188251
Published: 2023
Journal Articles

A First-in-Human Phase 1, Multicenter, Open-Label Study of CB-010, a Next-Generation CRISPR-Edited Allogeneic Anti-CD19 CAR-T Cell Therapy with a PD-1 Knockout, in Patients with Relapsed/Refractory B Cell Non-Hodgkin Lymphoma (ANTLER Study)

Susan O'Brien, Loretta J. Nastoupil, James Essell, Ly Dsouza, Doug Hart, Emiri Matsuda, Tarah Satterfield, Tonia Nesheiwat, Ashley Hammad, Franco Davi, Shally Chung, S. Asim Shamsi, Mara Bryan, Justin Skoble, Elizabeth Garner, Steven Kanner, Syed Rizvi, Houston Holmes
Journal: Blood
Blood (2022) 140 (Supplement 1): 9457–9458.
https://doi.org/10.1182/blood-2022-168128
Published: 2022
Journal Articles

Bion-1301, a First-in-Class APRIL Neutralizing Antibody for the Treatment of Multiple Myeloma: Preclinical Safety, and Analysis of Pharmacokinetics — Pharmacodynamics Relationship

John Dulos, PhD, Lilian Driessen, Bsc, Peter van Zandvoort, Bsc, Jos van de Crommert, Bsc, Justin Skoble, PhD, Nitya Nair, Msc, Britta Randlev, Bsc, Eduard de Cock, Msc, Jeroen Elassaiss Schaap, PhD, Hans Eenennaam, PhD, Andrea van Elsas, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1827.
https://doi.org/10.1182/blood.V130.Suppl_1.1827.1827
Published: 2017